1.
Gautam Borthakur, Hagop Kantarjian, Farhad Ravandi, Weiguo Zhang, Marina Konopleva, John J. Wright, Stefan Faderl, Srdan Verstovsek, Sheela Mathews, Michael Andreeff, Jorge E. Cortes. Phase I study of sorafenib in patients with refractory or relapsed acute leukemias. haematol [Internet]. 2010Dec.30 [cited 2024Apr.20];96(1):62-8. Available from: https://haematologica.org/article/view/5853